Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 5,963,000 | 5,350,000 |
| Cost of Goods | 1,442,000 | 1,492,000 |
| Gross Profit | 4,521,000 | 3,858,000 |
| Operating Expenses | 2,944,000 | 2,887,000 |
| Operating Income | 1,577,000 | 971,000 |
| Other Income | -17,000 | -971,000 |
| Pre-tax Income | 1,560,000 | N/A |
| Income Tax | 611,000 | N/A |
| Net Income Continuous | 999,000 | 625,000 |
| Minority Interests | -14,000 | N/A |
| Net Income | $985,000 | $625,000 |
| EPS Basic Total Ops | 1.35 | 0.85 |
| EPS Basic Continuous Ops | 1.35 | 0.85 |
| EPS Diluted Total Ops | 1.35 | 0.85 |
| EPS Diluted Continuous Ops | 1.35 | 0.85 |
| EBITDA(a) | $1,818,000 | $1,207,000 |